Search - tctmd.com

Displaying 121 - 140 of 477

Sort: Relevancy | Date

Presentation TCT 2019

LM PCI: The Default Is Prolonged DAPT (>1 year)!

Presenter: Robert Yeh

September 27, 2019

Presentation TCT 2019

Clinical Insights: The Evidence and Technique Behind Orbital Atherectomy

Presenter: Ajay Kirtane

September 27, 2019

Presentation TCT 2019

New Insights on Orbital Technology

Presenter: Jeffrey Chambers

September 27, 2019

Presentation TCT 2019

Taking Control: Treatment Planning in Complex PCI

Presenter: Sandeep Nathan

September 27, 2019

Presentation TCT 2019

Japan's Interventional Practice: Japan's Experience With Imaging in the Complex PCI Patient Population

Presenter: takashi ashikaga

September 27, 2019

Presentation TCT 2019

The Changing Interventional Practice: Managing a Complex PCI Patient Population

Presenter: Richard Shlofmitz

September 27, 2019

Presentation TCT 2019

Clinical Trial Design in HBR Patients: Should Risk Scores Be Incoporated?

Presenter: Davide Capodanno

September 27, 2019

Presentation TCT 2019

Case 2: How Microcirculatory Function Testing Changed My Management in a Patient Without Significant CAD

Presenter: Bruce Samuels

September 26, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

News TCT 2019

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Shelley Wood

September 26, 2019

Presentation TCT 2019

EVOLVE Short DAPT: A Single-Arm Study of 3-Month DAPT in Patients at High Bleeding Risk Treated With a Bioabsorbable Polymer-Based Everolimus-Eluting Stent

Presenter: Ajay Kirtane

September 26, 2019

https://www.tctmd.com/news/ideal-lm-probes-short-dapt-and-bioabsorbable-polymer-stent-left-main-disease

News Conference News TCT 2019

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Michael O'Riordan

September 26, 2019

Presentation TCT 2019

Case Resolution: How Did I Treat and What Happened?

Presenter: Amit Vora

September 26, 2019

Presentation TCT 2019

The Approach to the High Bleeding Risk Patient: The Dos and the Don’ts!

Presenter: Bernard Chevalier

September 26, 2019

Presentation TCT 2019

Long-Term Antithrombotic Therapy After PCI: How Do I Incorporate COMPASS Into My Practice?

Presenter: Robert Welsh

September 26, 2019

Presentation TCT 2019

De-Escalation: When and How? — The Role of Platelet Function and Genetic Testing

Presenter: Francesco Franchi

September 26, 2019

News Conference News TCT 2019

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Yael L. Maxwell

September 26, 2019

Presentation TCT 2019

Insights From SMART CHOICE

Presenter: Joo-Yong Hahn

September 26, 2019

Presentation TCT 2019

Insights From STOP DAPT-2

Presenter: Takeshi Kimura

September 26, 2019

Presentation TCT 2019

Insights From TWILIGHT

Presenter: Usman Baber

September 26, 2019

Advertisement

LM PCI: The Default Is Prolonged DAPT (>1 year)!

Clinical Insights: The Evidence and Technique Behind Orbital Atherectomy

New Insights on Orbital Technology

Taking Control: Treatment Planning in Complex PCI

Japan's Interventional Practice: Japan's Experience With Imaging in the Complex PCI Patient Population

The Changing Interventional Practice: Managing a Complex PCI Patient Population

Clinical Trial Design in HBR Patients: Should Risk Scores Be Incoporated?

Case 2: How Microcirculatory Function Testing Changed My Management in a Patient Without Significant CAD

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

EVOLVE Short DAPT: A Single-Arm Study of 3-Month DAPT in Patients at High Bleeding Risk Treated With a Bioabsorbable Polymer-Based Everolimus-Eluting Stent

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Case Resolution: How Did I Treat and What Happened?

The Approach to the High Bleeding Risk Patient: The Dos and the Don’ts!

Long-Term Antithrombotic Therapy After PCI: How Do I Incorporate COMPASS Into My Practice?

De-Escalation: When and How? — The Role of Platelet Function and Genetic Testing

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Insights From SMART CHOICE

Insights From STOP DAPT-2

Insights From TWILIGHT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content